Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3. This appears to be an internal documentation/version update and does not alter the study details or results.
    Difference
    0.1%
    Check dated 2026-03-18T21:19:55.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. The change reflects a version label update with no alterations to page content or functionality.
    Difference
    0.1%
    Check dated 2026-03-11T18:00:14.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Addition: Revision: v3.4.2 is now active; the previous government funding lapse notice (v3.4.1) has been removed, reflecting administrative site-wide updates rather than study data changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:46:00.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a government funding notice stating information may not be up to date and directing users to status updates. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:57:19.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Show glossary by default and minor labeling changes (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:16:06.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study data, eligibility criteria, or locations observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:36:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.